HireQuest (HQI) said Monday it's "disappointed" with the TrueBlue (TBI) board's rejection of its proposal to buy TrueBlue for $7.50 per share.
The company said it has filed a merger presentation with the US Securities and Exchange Commission and is encouraging TrueBlue's shareholders to review it.
HireQuest Chief Executive Rick Hermanns said the company is open to potentially increasing its offer and adding a material cash component, although it believes that it's $7.50 per share offer represents a "compelling" premium and is fair.
TrueBlue said Wednesday it adopted a limited-duration shareholder rights plan, or "poison pill," to protect investor interests in response to HireQuest's takeover offer. TrueBlue said the plan, which expires May 13, 2026, would prevent any group from gaining control without paying a fair premium or providing the board with enough time to act.
TrueBlue didn't immediately respond to a request for comment by MT Newswires on Monday.
Shares of HireQuest were down 1.7% in early trading Monday, while TrueBlue stock is up 1.3%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。